Edition:
United Kingdom

vTv Therapeutics Inc (VTVT.OQ)

VTVT.OQ on NASDAQ Stock Exchange Global Market

6.85USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$6.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
49,218
52-wk High
$8.37
52-wk Low
$3.63

Select another date:

Thu, Dec 21 2017

BRIEF-Vtv Therapeutics, Reneo Pharmaceuticals Enter Licensing Agreement

* VTV THERAPEUTICS AND RENEO PHARMACEUTICALS ENTER LICENSING AGREEMENT FOR PPAR-DELTA PROGRAM

BRIEF-vTv Therapeutics Signs Agreement With Hangzhou Zhongmei For Rights of Glp-1R Agonist Diabetes Program

* VTV THERAPEUTICS INC SAYS LICENSING AGREEMENT WITH HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO. TO RIGHTS FOR VTV'S GLP-1R AGONIST DIABETES PROGRAM

BRIEF-VTv Therapeutics Entered Into Agreement With MacAndrews & Forbes

* VTV THERAPEUTICS SAYS ON DEC 5, CO ENTERED INTO A LETTER AGREEMENT WITH MACANDREWS & FORBES GROUP LLC - SEC FILING

BRIEF-vTv Therapeutics reports Q3 GAAP loss per share of $0.38

* vTv Therapeutics reports third quarter 2017 financial and operational results

BRIEF-JDRF, VTV Therapeutics collaborate on Phase 2 study of novel treatment for type 1 diabetes

* JDRF and VTV Therapeutics announce collaboration on Phase 2 study of novel treatment for Type 1 diabetes

Select another date: